What Is Tension-Type Headache? Symptoms, Causes and Treatment
Tension-type headache is the most common primary headache worldwide. What it feels like, how it differs from migraine, what drives it, and the evidence behind treatment.
- •Tension-type headache (TTH) is the most common primary headache worldwide, affecting approximately 26% of the general population across a lifetime (Martín-Vera et al., Frontiers in Neurology, 2023).
- •Pain is typically bilateral (both sides), pressing or tightening — not throbbing — and mild to moderate in intensity.
- •Both peripheral factors (muscle tension, trigger points) and central pain processing changes contribute to TTH, particularly in the chronic form.
- •Physical therapy combining manual therapy and progressive exercise is effective and well-evidenced; it performs comparably to medication for reducing headache frequency.
Want to apply this context to your own experience?
See how the App worksTension-type headache is so common that many people consider it "just a headache" — but for those who experience it frequently or chronically, the impact on daily life is significant. This article explains what TTH is, how it differs from migraine, what drives it, and what the evidence says about managing it.
What is tension-type headache?
Tension-type headache (TTH) is a primary headache disorder — a condition in its own right, not a symptom of something else. It is the most prevalent headache type globally, with a lifetime prevalence of around 26% in the general population (Martín-Vera et al., 2023). The World Health Organization lists it among the ten most disabling conditions for both men and women (WHO).
Despite its prevalence, TTH receives considerably less clinical attention than migraine. Research funding and treatment innovation have lagged, and unlike migraine, there are currently no established targeted therapies addressing the specific neurobiological mechanisms of TTH (Park & Oh, Health and Patient Relations, 2024).
TTH is classified by the ICHD-3 into three subtypes based on frequency:
- Infrequent episodic TTH — fewer than 12 headache days per year
- Frequent episodic TTH — 12 to 180 headache days per year
- Chronic TTH — 180 or more headache days per year (i.e., headache on at least 15 days per month for more than three months)
Chronic TTH has a substantially higher impact on quality of life, healthcare use, and work productivity than the episodic forms (Toros & Bernstein, Journal of Headache and Pain, 2025).
What does tension-type headache feel like?
TTH has a recognisable pain quality that distinguishes it from migraine, though the two can overlap and even coexist in the same person.
Core features according to ICHD-3 diagnostic criteria include:
- Bilateral location — both sides of the head, often described as a band around the head
- Pressing or tightening quality — not pulsating or throbbing
- Mild to moderate intensity — not severe
- Not worsened by routine physical activity — unlike migraine
During a TTH episode, nausea and vomiting are absent, and light and sound sensitivity — while they can occur — are not both present simultaneously at significant levels (ICHD-3). This is one of the key diagnostic distinctions from migraine.
Pericranial muscle tenderness — sensitivity on palpation of the muscles around the skull, including the temporalis, trapezius, suboccipital, and sternocleidomastoid — is common and clinically relevant. Patients with TTH show lower pressure pain thresholds in these muscles compared to headache-free individuals, reflecting an altered pain processing state (Martín-Vera et al., 2023).
What causes tension-type headache?
The pathophysiology of TTH is not fully understood — a situation that distinguishes it from most other major headache types. Both peripheral and central mechanisms contribute, and their relative importance appears to shift as the condition progresses from episodic to chronic (Toros & Bernstein, Journal of Headache and Pain, 2025).
Peripheral mechanisms are the primary drivers in episodic TTH. These include:
- Increased tenderness and hardness in pericranial muscles
- Myofascial trigger points (MTrPs) — hyperirritable spots within taut muscle bands that generate referred pain
- Increased nociceptive (pain signal) input from neck and head muscles to the trigeminal pain pathway
People with TTH tend to have muscles that are harder, more tender to palpation, and more frequently populated with trigger points than people without headache (Robbins & Crystal, Current Pain and Headache Reports, 2010).
Central sensitisation — where the central nervous system becomes more reactive and amplifies pain signals — plays a greater role in chronic TTH. Neuroimaging and neurophysiological studies demonstrate altered pain processing in cortical and subcortical brain regions in people with chronic TTH (Toros & Bernstein, 2025). This central component is one reason why chronic TTH can be harder to treat and why psychological factors — particularly anxiety, stress, and sleep disruption — are closely intertwined with its severity and persistence.
Genetic factors, hormonal influences, and psychosocial stressors all contribute. TTH is more prevalent in women than men, with a ratio of approximately 3:2 (Martín-Vera et al., 2023).
How is tension-type headache diagnosed?
Diagnosis is based entirely on clinical history, assessed against ICHD-3 criteria. There are no diagnostic tests, blood markers, or imaging findings that confirm TTH. Neuroimaging and other investigations are reserved for cases where a secondary headache cause is suspected.
The diagnostic challenge is that TTH shares features with several other headache types. Migraine without aura can resemble TTH — particularly when migraine attacks are mild. Both TTH and migraine can also coexist in the same person, and medication-overuse headache can develop on a background of either condition when acute medication is taken too frequently (ICHD-3). Distinguishing between these diagnoses requires careful clinical history.
HeadacheRecovery is a tracking and self-management tool, not a diagnostic service. Consistently recording headache frequency, duration, intensity, associated symptoms, and medication use days provides the structured data that helps your clinician make an accurate diagnosis and monitor treatment response over time.
How tension-type headache differs from migraine
Many people with TTH are uncertain whether they have migraine. The table below summarises the key clinical distinctions:
| Feature | Tension-Type Headache | Migraine |
|---|---|---|
| Location | Bilateral (both sides) | Often unilateral |
| Pain quality | Pressing/tightening | Pulsating/throbbing |
| Intensity | Mild to moderate | Moderate to severe |
| Physical activity | Not worsened | Typically worsened |
| Nausea/vomiting | Absent | Common |
| Light and sound sensitivity | Mild if present | Often marked |
| Aura | Not a feature | In ~25–30% of cases |
| Duration | 30 min–7 days | 4–72 hours |
It is important to note that both conditions can coexist, and a single person may have both TTH and migraine diagnosed — this is not uncommon (Torelli & Manzoni, Journal of Headache and Pain, 2023).
Treatment: what does the evidence show?
Physical therapy
Physical therapy is the most evidence-supported non-pharmacological treatment for TTH and is considered comparably effective to medication for reducing headache frequency. A network meta-analysis of 20 randomised controlled trials found that manual therapy (joint mobilisation) combined with exercise produced the greatest reduction in headache frequency (mean difference vs usual care: −13.95 days/month, moderate confidence), while transcutaneous electrical stimulation combined with physiotherapy produced the greatest reduction in pain intensity (mean difference: −3.8, moderate confidence) (Donmez et al., Cephalalgia, 2022).
Multiple systematic reviews confirm that no single physical therapy technique is effective in isolation — combined approaches are consistently superior to single-technique treatments (Cumplido-Trasmonte et al., PMC, 2015; Donmez et al., 2022).
Effective physical therapy approaches for TTH include:
- Manual therapy — joint mobilisation of the cervical and thoracic spine, suboccipital inhibition, and myofascial release
- Cervical and craniocervical exercise — particularly targeting the deep neck flexors, which are consistently shown to be weaker in people with chronic TTH
- Neck and shoulder strengthening — a 12-week progressive resistance training programme produced significant reductions in headache intensity and duration, and increased deep cervical muscle thickness and pain pressure thresholds, compared to a control group (Martín-Vera et al., Frontiers in Neurology, 2023)
- Postural correction — particularly relevant where sustained poor posture is a contributing factor
- Relaxation training and aerobic exercise — muscle relaxation techniques and aerobic activity are supported by meta-analysis for reducing headache intensity and frequency in chronic TTH (Güvercin & Kaya, ResearchGate, 2025)
Physiotherapists specialising in headache most commonly use manual therapy (96%), exercise (61%), and dry needling (48%), targeting the suboccipital and upper cervical regions — consistent with current evidence (Luces-Trilla et al., JCMS Applied Neurosciences, 2026).
Psychological and lifestyle interventions
Cognitive-behavioural therapy (CBT) and stress management are recognised components of TTH management, particularly for chronic TTH with significant psychosocial contributors (Toros & Bernstein, 2025). Sleep hygiene, regular physical activity, and consistent daily routines (including regular mealtimes) reduce attack frequency by stabilising the nervous system's sensitivity.
Where medication fits
Medicines have a role for some people, but which one — if any — is a decision for your GP or specialist, and nothing here is a recommendation. What matters from a tracking point of view is frequency: taking acute pain relief on 10–15 or more days per month is associated with medication-overuse headache, so recording your medication days is one of the most important steps in avoiding that complication (ICHD-3).
When to seek help
Seek urgent medical attention if you experience a sudden, severe headache reaching peak intensity within seconds to minutes (a SNOOP red flag: sudden Onset), any new neurological symptoms such as weakness, speech changes, or vision loss, a headache with fever and neck stiffness, or a new headache type developing after age 50 (Older age of onset). These features are not consistent with tension-type headache and need immediate assessment. If your headache pattern has changed significantly — another SNOOP red flag (Pattern change) — this also warrants medical review regardless of your existing headache history.
Key takeaways
- ✓TTH is the most common primary headache globally, affecting around 26% of people across a lifetime, yet it receives disproportionately less research and clinical attention than migraine.
- ✓Pain is bilateral, pressing, and mild to moderate — not throbbing, and not significantly worsened by physical activity.
- ✓Both peripheral muscle dysfunction and, in chronic TTH, central sensitisation drive the condition; they require different management approaches.
- ✓Physical therapy combining manual therapy and progressive exercise is the most evidence-supported non-pharmacological treatment, with effects comparable to medication for headache frequency.
- ✓Tracking headache days and medication use consistently — using HeadacheRecovery's journal — gives your clinician the data needed to monitor progression and avoid medication overuse.
Frequently asked questions
Related guides
From general guide to your own pattern
This guide covers the general picture. The App records your specific pattern — timing, triggers, sleep, stress and medication use — and turns it into a summary report you can discuss with your primary healthcare provider.
Medical disclaimer: This article is for educational purposes only and is not a substitute for medical advice. Always consult your GP or specialist for diagnosis and acute care.
On medication: HeadacheRecovery takes a non-pharmacological, tracking-based approach. Where research on medicines is mentioned it is background context only, not a recommendation. Any decision to start, stop or change a medicine belongs with your prescribing clinician.